Altered expression of p120catenin predicts poor outcome in invasive breast cancer

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 9, 2010, Pages 1377-1387

  Talvinen, K ^a   Tuikkala, J ^a   Nykanen M ^b   Nieminen, A ^b   Anttinen, J ^b   Nevalainen, O S ^a   Hurme, S ^a   Kuopio, T ^b   Kronqvist, P ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

Author keywords

Breast cancer; Gene expression; Immunohistochemistry; Microarray; P120catenin; Prognosis

Indexed keywords

ALPHA CATENIN; ANTIESTROGEN; CATENIN; CYTOSTATIC AGENT; ISOPROTEIN; PROTEIN P120; UVOMORULIN; DELTA CATENIN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER MORTALITY; CANCER SURVIVAL; CANCER THERAPY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TISSUE MICROARRAY; BIOSYNTHESIS; BREAST TUMOR; CANCER INVASION; DISEASE COURSE; DNA MICROARRAY; FOLLOW UP; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; SURVIVAL;

AGED; BREAST NEOPLASMS; CATENINS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN ISOFORMS; SURVIVAL ANALYSIS;

EID: 77955502340     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-010-0789-8     Document Type: Article

References (66)

1. S Aho L Levänsuo O Montonen C Kari U Rodeck J Uitto 2002 Specific sequences in p120ctn determine subcellular distribution of its multiple isoforms involved in cellular adhesion of normal and malignant epithelial cells J Cell Sci 115 1391 1402 1:CAS:528:DC%2BD38Xjt1Gntrc%3D 11896187
2. DI Bellovin RC Bates A Muzikansky DL Rimm AM Mercurio 2005 Altered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive disease Cancer Res 65 10938 10945 10.1158/0008-5472.CAN-05-1947 1:CAS:528:DC%2BD2MXht1KjsrzO 16322241
3. G Berx AM Cleton-Jansen K Strumane WJ de Leeuw F Nollet F van Roy C Cornelisse 1996 E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain Oncogene 13 1919 1925 1:CAS:528:DyaK28Xnt1Olsro%3D 8934538
4. IK Bukholm JM Nesland R Kåresen U Jacobsen AL Børresen-Dale 1998 E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma J Pathol 185 262 266 10.1002/(SICI)1096-9896(199807)185:3<262::AID-PATH97>3.0.CO;2-Y 1:CAS:528:DyaK1cXlsVOhtro%3D 9771479
5. LA Carey CM Perou CA Livasy LG Dressler D Cowan K Conway G Karaca MA Troester CK Tse S Edmiston SL Deming J Geradts MC Cheang TO Nielsen PG Moorman HS Earp RC Millikan 2006 Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 2492 2502 10.1001/jama.295.21.2492 1:CAS:528:DC%2BD28XlsV2rtLw%3D 16757721
6. Y Chung AK Lam JM Luk S Law KW Chan PY Lee J Wong 2007 Altered E-cadherin expression and p120 catenin localization in esophageal squamous cell carcinoma Ann Surg Oncol 14 3260 3267 10.1245/s10434-007-9511-8 17647062
7. PE Corsino BJ Davis PH Nørgaard NN Parker M Law W Dunn BK Law 2008 Mammary tumors initiated by constitutive Cdk2 activation contain an invasive basal-like component Neoplasia 10 1240 1252 1:CAS:528:DC%2BD1cXhtlagtrzM 18953433
8. L Da Silva S Parry L Reid P Keith N Waddell M Kossai C Clarke SR Lakhani PT Simpson 2008 Aberrant expression of E-cadherin in lobular carcinomas of the breast Am J Surg Pathol 32 773 783 10.1097/PAS.0b013e318158d6c5 18379416
9. DJ Dabbs R Bhargava M Chivukula 2007 Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin Am J Surg Pathol 31 427 437 10.1097/01.pas.0000213386.63160.3f 17325485
10. DJ Dabbs M Kaplai M Chivukula A Kanbour A Kanbour-Shakir GJ Carter 2007 The spectrum of morphomolecular abnormalities of the E-cadherin/catenin complex in pleomorphic lobular carcinoma of the breast Appl Immunohistochem Mol Morphol 15 260 266 10.1097/01.pai.0000213128.78665.3c 1:CAS:528:DC%2BD2sXhtFGqu7bI 17721269
11. JM Daniel AB Reynolds 1999 The catenin p120(ctn) interacts with Kaiso, a novel BTB/POZ domain zinc finger transcription factor Mol Cell Biol 19 3614 3623 1:CAS:528:DyaK1MXislSlu7c%3D 10207085
12. JM Daniel CM Spring HC Crawford AB Reynolds A Baig 2002 The p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides Nucleic Acids Res 30 2911 2919 10.1093/nar/gkf398 1:CAS:528:DC%2BD38XlsFCqsLs%3D 12087177
13. MA Davis RC Ireton AB Reynolds 2003 A core function for p120-catenin in cadherin turnover J Cell Biol 163 525 534 10.1083/jcb.200307111 1:CAS:528:DC%2BD3sXovFCnurk%3D 14610055
14. WJ De Leeuw G Berx CB Vos JL Peterse MJ Van de Vijver S Litvinov F Van Roy CJ Cornelisse AM Cleton-Jansen 1997 Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ J Pathol 183 404 411 10.1002/(SICI)1096-9896(199712)183:4<404::AID- PATH1148>3.0.CO;2-9 9496256
15. NN Esposito M Chivukula DJ Dabbs 2007 The ductal phenotypic expression of the E-cadherin/catenin complex in tubulolobular carcinoma of the breast: an immunohistochemical and clinicopathologic study Mod Pathol 20 130 138 10.1038/modpathol.3800721 1:CAS:528:DC%2BD28XhtlaktrbI 17143261
16. ER Fisher S Anderson S Dean D Dabbs B Fisher R Siderits J Pritchard T Pereira C Geyer N Wolmark 2005 Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma Cancer 103 164 173 10.1002/cncr.20761 1:CAS:528:DC%2BD2MXmtVartA%3D%3D 15565575
17. JS Gold AB Reynolds DL Rimm 1998 Loss of p120ctn in human colorectal cancer predicts metastasis and poor survival Cancer Lett 132 193 201 10.1016/S0304-3835(98)00190-6 1:STN:280:DyaK1MzitlKjsQ%3D%3D 10397474
18. BE Gould Rothberg MB Bracken 2006 E-cadherin immunohistochemical expression as a prognostic factor in infiltrating ductal carcinoma of the breast: a systematic review and meta-analysis Breast Cancer Res Treat 100 139 148 10.1007/s10549-006-9248-2 1:CAS:528:DC%2BD28XhtFWlur%2FE 16791476
19. I Grosheva M Shtutman M Elbaum AD Bershadsky 2001 p120 catenin affects cell motility via modulation of activity of Rho-family GTPases: a link between cell-cell contact formation and regulation of cell locomotion J Cell Sci 114 695 707 1:CAS:528:DC%2BD3MXitFWltrY%3D 11171375
20. J Husmark NE Heldin M Nilsson 1999 N-cadherin-mediated adhesion and aberrant catenin expression in anaplastic thyroid-carcinoma cell lines Int J Cancer 83 692 699 10.1002/(SICI)1097-0215(19991126)83:5<692::AID-IJC21>3. 0.CO;2-1 1:CAS:528:DyaK1MXns1alsLs%3D 10521809
21. RC Ireton MA Davis J van Hengel DJ Mariner K Barnes MA Thoreson PZ Anastasiadis L Matrisian LM Bundy L Sealy B Gilbert F van Roy AB Reynolds 2002 A novel role for p120 catenin in E-cadherin function J Cell Biol 159 465 476 10.1083/jcb.200205115 1:CAS:528:DC%2BD38XoslKmt78%3D 12427869
22. Y Ishizaki Y Omori M Momiyama Y Nishikawa T Tokairin M Manabe K Enomoto 2004 Reduced expression and aberrant localization of p120catenin in human squamous cell carcinoma of the skin J Dermatol Sci 34 99 108 10.1016/j.jdermsci.2003.12.001 1:CAS:528:DC%2BD2cXitFChs7o%3D 15033192
23. AJ Karayiannakis L Nakopoulou H Gakiopoulou A Keramopoulos PS Davaris M Pignatelli 2001 Expression patterns of beta-catenin in in situ and invasive breast cancer Eur J Surg Oncol 27 31 36 10.1053/ejso.1999.1017 1:STN:280:DC%2BD3M7osFWlsQ%3D%3D 11237489
24. A Keirsebilck S Bonné K Staes J van Hengel F Nollet A Reynolds F van Roy 1998 Molecular cloning of the human p120ctn catenin gene (CTNND1): expression of multiple alternatively spliced isoforms Genomics 50 129 146 10.1006/geno.1998.5325 1:CAS:528:DyaK1cXktFOgs7Y%3D 9653641
25. KF Kelly CM Spring AA Otchere JM Daniel 2004 NLS-dependent nuclear localization of p120ctn is necessary to relieve Kaiso-mediated transcriptional repression J Cell Sci 117 2675 2686 10.1242/jcs.01101 1:CAS:528: DC%2BD2cXlvFehtrc%3D 15138284
26. J Kononen L Bubendorf A Kallioniemi M Barlund P Schraml S Leighton J Torhorst MJ Mihatsch G Sauter OP Kallioniemi 1998 Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 4 844 847 10.1038/nm0798-844 1:CAS:528:DyaK1cXktlKntr8%3D 9662379
27. G Liapis E Mylona P Alexandrou I Giannopoulou I Nikolaou S Markaki A Keramopoulos L Nakopoulou 2007 Effect of the different phosphorylated Smad2 protein localizations on the invasive breast carcinoma phenotype APMIS 115 104 114 10.1111/j.1600-0463.2007.apm-517.x 1:CAS:528:DC%2BD2sXjsFektbw%3D 17295676
28. Y Liu HT Xu SD Dai Q Wei XM Yuan EH Wang 2007 Reduction of p120(ctn) isoforms 1 and 3 is significantly associated with metastatic progression of human lung cancer APMIS 115 848 856 10.1111/j.1600-0463.2007.apm-673.x 1:CAS:528:DC%2BD2sXhtVeisbbN 17614852
29. L Lo Muzio G Pannone S Staibano MD Mignogna R Serpico S Fanali G De Rosa A Piattelli MA Mariggiò 2002 p120(cat) Delocalization in cell lines of oral cancer Oral Oncol 38 64 72 10.1016/S1368-8375(01)00027-6 1:CAS:528:DC%2BD38XisVGq 11755823
30. TL Mastracci S Tjan AL Bane FP O'Malley IL Andrulis 2005 E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast Mod Pathol 18 741 751 10.1038/modpathol.3800362 1:CAS:528: DC%2BD2MXktlWitLg%3D 15696125
31. J Mayerle H Friess MW Büchler J Schnekenburger FU Weiss KP Zimmer W Domschke MM Lerch 2003 Up-regulation, nuclear import, and tumor growth stimulation of the adhesion protein p120 in pancreatic cancer Gastroenterology 124 949 960 10.1053/gast.2003.50142 1:CAS:528:DC%2BD3sXjsFOju70%3D 12671892
32. YY Mo AB Reynolds 1996 Identification of murine p120 isoforms and heterogeneous expression of p120cas isoforms in human tumor cell lines Cancer Res 56 2633 2640 1:CAS:528:DyaK28XjtlCgu78%3D 8653709
33. L Nakopoulou H Gakiopoulou-Givalou AJ Karayiannakis I Giannopoulou A Keramopoulos P Davaris M Pignatelli 2002 Abnormal alpha-catenin expression in invasive breast cancer correlates with poor patient survival Histopathology 40 536 546 10.1046/j.1365-2559.2002.01392.x 1:STN:280:DC%2BD38zmsVartQ%3D%3D 12047765
34. J Paredes AL Correia AS Ribeiro F Schmitt 2007 Expression of p120-catenin isoforms correlates with genomic and transcriptional phenotype of breast cancer cell lines Cell Oncol 29 467 476 1:CAS:528:DC%2BD2sXhtlajtL%2FI 18032823
35. J Paredes AL Correia AS Ribeiro F Milanezi J Cameselle-Teijeiro FC Schmitt 2008 Breast carcinomas that co-express E- ja P-cadherin are associated with p120-catenin cytoplasmic localisation and poor patient survival J Clin Pathol 61 856 862 10.1136/jcp.2007.052704 1:STN:280:DC%2BD1cvhsFegtg%3D%3D 18381381
36. A Prokhortchouk B Hendrich H Jørgensen A Ruzov M Wilm G Georgiev A Bird E Prokhortchouk 2001 The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor Genes Dev 15 1613 1618 10.1101/gad.198501 1:CAS:528:DC%2BD3MXltFKqt70%3D 11445535
37. EA Rakha D Abd El Rehim SE Pinder SA Lewis IO Ellis 2005 E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance Histopathology 46 685 693 10.1111/j.1365-2559.2005.02156.x 1:STN:280:DC%2BD2M3mvV2isw%3D%3D 15910600
38. AB Reynolds DJ Roesel SB Kanner JT Parsons 1989 Transformation-specific tyrosine phosphorylation of a novel cellular protein in chicken cells expressing oncogenic variants of the avian cellular src gene Mol Cell Biol 9 629 638 1:CAS:528:DyaL1MXhtlaru78%3D 2469003
39. AB Reynolds L Herbert JL Cleveland ST Berg JR Gaut 1992 p120, a novel substrate of protein tyrosine kinase receptors and of p60v-src, is related to cadherin-binding factors beta-catenin, plakoglobin and armadillo Oncogene 7 2439 2445 1:CAS:528:DyaK3sXltFWmsLc%3D 1334250
40. S Roura D Domínguez 2004 Inducible expression of p120Cas1B isoform corroborates the role for p120-catenin as a positive regulator of E-cadherin function in intestinal cancer cells Biochem Biophys Res Commun 320 435 441 10.1016/j.bbrc.2004.05.186 1:CAS:528:DC%2BD2cXlt1egtrc%3D 15219847
41. D Sarrió B Pérez-Mies D Hardisson G Moreno-Bueno A Suárez A Cano J Martín-Pérez C Gamallo J Palacios 2004 Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions Oncogene 23 3272 3283 10.1038/sj.onc.1207439 15077190
42. T Shibata A Kokubu S Sekine Y Kanai S Hirohashi 2004 Cytoplasmic p120ctn regulates the invasive phenotypes of E-cadherin-deficient breast cancer Am J Pathol 164 2269 2278 1:CAS:528:DC%2BD2cXltFymtr4%3D 15161659
43. B Silva Neto GL Smith JA Mandeville AJ Vanni C Wotkowicz KM Rieger-Christ E Baumgart MA Jacobs MS Cohen R Zeheb M Loda JA Libertino IC Summerhayes 2008 Prognostic significance of altered p120 ctn expression in bladder cancer BJU Int 101 746 752 10.1111/j.1464-410X.2007.07264.x 17922855
44. CM Spring KF Kelly I O'Kelly M Graham HC Crawford JM Daniel 2005 The catenin p120ctn inhibits Kaiso-mediated transcriptional repression of the beta-catenin/TCF target gene matrilysin Exp Cell Res 305 253 265 10.1016/j.yexcr.2005.01.007 1:CAS:528:DC%2BD2MXivFyqu7o%3D 15817151
45. IM Stefansson HB Salvesen LA Akslen 2004 Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer J Clin Oncol 22 1242 1252 10.1200/JCO.2004.09.034 1:CAS:528: DC%2BD2cXpsVGktLY%3D 15051772
46. M Tajine D Elizondo 2002 New methods for testing linear separability Neurocomputing 47 161 188 10.1016/S0925-2312(01)00587-2
47. K Talvinen J Tuikkala J Grönroos H Huhtinen P Kronqvist T Aittokallio O Nevalainen H Hiekkanen T Nevalainen J Sundström 2006 Biochemical and clinical approaches in evaluating the prognosis of colon cancer Anticancer Res 26 4745 4751 1:CAS:528:DC%2BD2sXps1Slug%3D%3D 17214335
48. K Talvinen J Tuikkala O Nevalainen A Rantanen P Hirsimäki J Sundström P Kronqvist 2008 Proliferation marker securin identifies favourable outcome in invasive ductal breast cancer Br J Cancer 99 335 340 10.1038/sj.bjc.6604475 1:CAS:528:DC%2BD1cXosFWnsLc%3D 18594525
49. Tavassoli FA, Devilee P (eds) (2003) World Health Organization Classification of Tumours. Pathology and genetics of tumours of the breast and female genital organs. IARC Press, Lyon, p 19
50. Theodoridis S, Koutroumbas K (2003) Pattern recognition. Academic Press, San Diego
51. MA Thoreson AB Reynolds 2002 Altered expression of the catenin p120 in human cancer: implications for tumour progression Differentiation 70 583 589 10.1046/j.1432-0436.2002.700911.x 1:CAS:528:DC%2BD3sXlt1ejsw%3D%3D 12492499
52. NL Tran RB Nagle AE Cress RL Heimark 1999 N-Cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion with stromal cells Am J Pathol 155 787 798 1:CAS:528:DyaK1MXmsVCrtLg%3D 10487836
53. BC Turner S Krajewski M Krajewska S Takayama AA Gumbs D Carter TR Rebbeck BG Haffty JC Reed 2001 BAG-1: a novel biomarker predicting long-term survival in early-stage breast cancer J Clin Oncol 19 992 1000 1:CAS:528: DC%2BD3MXhvFersbs%3D 11181661
54. JH van Es N Barker H Clevers 2003 You Wnt some, you lose some: oncogenes in the Wnt signaling pathway Curr Opin Genet Dev 13 28 33 10.1016/S0959-437X(02) 00012-6 12573432
55. J van Hengel P Vanhoenacker K Staes F van Roy 1999 Nuclear localization of the p120(ctn) Armadillo-like catenin is counteracted by a nuclear export signal and by E-cadherin expression Proc Natl Acad Sci USA 96 7980 7985 10.1073/pnas.96.14.7980 10393933
56. IM van Oort K Tomita A van Bokhoven MJ Bussemakers LA Kiemeney HF Karthaus JA Witjes JA Schalken 2007 The prognostic value of E-cadherin and the cadherin-associated molecules alpha-, beta-, gamma-catenin and p120ctn in prostate cancer specific survival: a long-term follow-up study Prostate 67 1432 1438 10.1002/pros.20626 17639504
57. FM van Roy PD McCrea 2005 A role for Kaiso-p120ctn complexes in cancer? Nat Rev Cancer 5 956 964 10.1038/nrc1752 16294216
58. CB Vos AM Cleton-Jansen G Berx WJ de Leeuw NT ter Haar F van Roy CJ Cornelisse JL Peterse MJ van de Vijver 1997 E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis Br J Cancer 76 1131 1133 1:CAS:528:DyaK2sXntlOnsrw%3D 9365159
59. EH Wang Y Liu HT Xu SD Dai N Liu CY Xie XM Yuan 2006 Abnormal expression and clinicopathologic significance of p120-catenin in lung cancer Histol Histopathol 21 841 847 16691536
60. BP Wijnhoven M Pignatelli WN Dinjens HW Tilanus 2005 Reduced p120ctn expression correlates with poor survival in patients with adenocarcinoma of the gastroesophageal junction J Surg Oncol 92 116 123 10.1002/jso.20344 1:CAS:528:DC%2BD2MXht1GiurfF 16231374
61. L Xie BK Law ME Aakre M Edgerton Y Shyr NA Bhowmick HL Moses 2003 Transforming growth factor beta-regulated gene expression in a mouse mammary gland epithelial cell line Breast Cancer Res 5 R187 R198 10.1186/bcr640 1:CAS:528:DC%2BD3sXnsFagtrY%3D 14580254
62. M Yanagisawa D Huveldt P Kreinest CM Lohse JC Cheville AS Parker JA Copland PZ Anastasiadis 2008 A p120 catenin isoform switch affects Rho activity, induces tumor cell invasion, and predicts metastatic disease J Biol Chem 283 18344 18354 10.1074/jbc.M801192200 1:CAS:528:DC%2BD1cXnsVCntrw%3D 18407999
63. YH Yang S Dudoit P Luu DM Lin V Peng J Ngai TP Speed 2002 Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation Nucleic Acids Res 30 e15 10.1093/nar/30.4.e15 11842121
64. HG Yoon DW Chan AB Reynolds J Qin J Wong 2003 N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso Mol Cell 12 723 734 10.1016/j.molcel.2003.08.008 1:CAS:528:DC%2BD3sXnvFGrt7o%3D 14527417
65. R Yoshida N Kimura Y Harada N Ohuchi 2001 The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer Int J Oncol 18 513 520 1:CAS:528:DC%2BD3MXhsFGltrs%3D 11179480
66. B Zhai HX Yan SQ Liu L Chen MC Wu HY Wang 2008 Reduced expression of P120 catenin in cholangiocarcinoma correlated with tumor clinicopathologic parameters World J Gastroenterol 14 3739 3744 10.3748/wjg.14.3739 1:CAS:528:DC%2BD1cXht1WlsrbP 18595142